Document is current
Any future updates will be listed below
-
Authors
Petersen, Bettina
Vesper, Iris
Pachwald, Bernhild
Dagenbach, Nicole
Buck, Sina http://orcid.org/0000-0001-8428-1038
Waldenmaier, Delia
Heinemann, Lutz
-
Funding
Funding for this research was provided by:
Roche Diabetes Care (n.a.)
- License Information
-
More Information
Article History
Received: 21 January 2020
Accepted: 31 December 2020
First Online: 18 January 2021
Ethics approval and consent to participate
: Not applicable
: Not applicable
: DW and SB are employees of the IfDT (Institut für Diabetes-Technologie, Forschungs- und Entwicklungsgesellschaft mbH an der Universität Ulm, Ulm, Germany), which carries out clinical studies on the evaluation of BG meters and medical devices for diabetes therapy on its own initiative and on behalf of various companies. IfDT has received speakers’ honoraria or consulting fees from Abbott, Ascensia, Dexcom, LifeScan, Menarini Diagnostics, Metronom Health, Novo Nordisk, Roche, Sanofi, Sensile, and Ypsomed.BP, IV, BP, and ND are employees of Roche Diabetes Care.LH is a consultant for a number of companies that develop novel diagnostic and therapeutic options for diabetes treatment, e.g., Roche Diabetes Care, Becton Dickinson, Lifecare, and Berlin-Chemie. LH is a shareholder of the Profil Institut für Stoffwechselforschung, Neuss, Germany, and ProSciento, San Diego, USA.
